1. Pinal-Fernandez, Iago, Casal-Dominguez, Maria, Mammen, Andrew L. 2018. Immune-Mediated Necrotizing Myopathy. In Current rheumatology reports, 20, 21. doi:10.1007/s11926-018-0732-6. https://pubmed.ncbi.nlm.nih.gov/29582188/
2. Li, Jiawen, Tang, Xiaofang, Xu, Jingjing, Yuan, Jinqing, Zhao, Xueyan. 2023. HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins. In BMC cardiovascular disorders, 23, 317. doi:10.1186/s12872-023-03285-w. https://pubmed.ncbi.nlm.nih.gov/37355634/
3. Huang, Wuqing, Xiao, Jun, Ji, Jianguang, Chen, Liangwan. 2021. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study. In eLife, 10, . doi:10.7554/eLife.73873. https://pubmed.ncbi.nlm.nih.gov/34866576/
4. Fang, Chunqiu, Pan, Jianheng, Qu, Ning, Zhang, Jingzhou, Han, Dong. 2022. The AMPK pathway in fatty liver disease. In Frontiers in physiology, 13, 970292. doi:10.3389/fphys.2022.970292. https://pubmed.ncbi.nlm.nih.gov/36203933/
5. Zhao, Xueyan, Tang, Xiaofang, Xu, Jingjing, Song, Lei, Yuan, Jinqing. 2022. Novel polymorphism of the HMGCR gene related to the risk of diabetes in premature triple-vessel disease patients. In The journal of gene medicine, 24, e3445. doi:10.1002/jgm.3445. https://pubmed.ncbi.nlm.nih.gov/35998373/
智鼠故事 
